bimekizumab,Adalimumab
ucb pharmaceuticals,abbvie
['bimekizumab', 'psoriatic arthritis']
exciting news for psoriatic arthritis patients! a recent study shows that bimekizumab helps control and attenuate disease activity, offering new hope for improved outcomes. read more about this promising treatment #rheumatology #eular2023
HCPLive Rheumatology provides clinically impactful news and updates for HCPs treating rheumatic disease.